// App-Quantinova.ai

3681 : Nischarin disruption promotes breast tumor development in mouse models

Researchers

Presenter

  • Shengli Dong

Principal Investigators

  • Suresh K. Alahari

Medical Centers

  • LSUHSC in New Orleans, New Orleans, LA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • AMP-activated protein kinase

Drug/Treatment

  • DE-074

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved